+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fenbendazole Market by Type, Disease Type, Sales Channel, Application, End User - Global Forecast 2025-2030- Product Image
Fenbendazole Market by Type, Disease Type, Sales Channel, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Fenbendazole Market by Type, Disease Type, Sales Channel, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013636
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fenbendazole Market grew from USD 810.27 million in 2023 to USD 874.69 million in 2024. It is expected to continue growing at a CAGR of 8.11%, reaching USD 1.39 billion by 2030.

Fenbendazole is an antiparasitic drug commonly used in veterinary medicine, primarily for treating parasitic infections in animals such as dogs, cats, horses, and livestock. It operates by inhibiting energy metabolism in parasites, thus effectively expelling them from the host organism. The necessity for Fenbendazole is driven by its broad-spectrum efficacy, safety profile, and minimal resistance development among end-users like veterinary clinics, animal farms, and households with pets. As awareness of animal welfare grows, the demand for Fenbendazole is steadily increasing, primarily within developed countries, where pet ownership, livestock care standards, and agricultural productivity are prioritized. Growth factors propelling the market include increasing pet adoption rates, heightened awareness of parasitic health risks, and advancements in veterinary healthcare. As human-pet relationships deepen, the demand for animal health products rises, creating opportunities in developing regions through enhanced veterinary infrastructure. Noteworthy opportunities exist in expanding Fenbendazole applications to exotic animals and integrating natural and organic formulations, as trends toward holistic and sustainably-driven animal health products emergence. However, the market faces challenges including regulatory hurdles, potential side effects, and competition from alternative antiparasitic drugs, narrowing adoption possibilities. Innovation could focus on developing combination therapies to enhance efficacy or lessen parasite resistance and diversifying delivery methods for ease of administration, such as flavored tablets or injectables. The market is moderately fragmented with competition among pharmaceutical companies, and economies of scale can benefit larger players. Collaboration and strategic partnerships could assist new entrants in navigating regulatory landscapes and achieving competitive pricing. Constant research into parasite resistance patterns and product efficacy optimizations are vital for sustaining market versatility. Overall, successful market penetration requires combining robust research and product innovation with strategic market positioning.

Understanding Market Dynamics in the Fenbendazole Market

The Fenbendazole Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing supportive regulatory policies for the approval and usage of fenbendazole in animal healthcare
    • Rising pet ownership rates globally stimulating the demand for broad-spectrum anthelmintics
    • Intensive livestock farming practices raising the necessity for effective parasitic control solutions
  • Market Restraints
    • Cost constraints in developing fenbendazole formulations suited for diverse species
  • Market Opportunities
    • Developing combination treatments involving fenbendazole for more comprehensive animal health coverage
    • Introduction of fenbendazole in wildlife management programs to control parasite infestations
  • Market Challenges
    • Environmental concerns surrounding fenbendazole's residual impact in agricultural ecosystems

Exploring Porter’s Five Forces for the Fenbendazole Market

Porter’s Five Forces framework further strengthens the insights of the Fenbendazole Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Fenbendazole Market

External macro-environmental factors deeply influence the performance of the Fenbendazole Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Fenbendazole Market

The Fenbendazole Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Fenbendazole Market

The Fenbendazole Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Fenbendazole Market

The Fenbendazole Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fenbendazole Market, highlighting leading vendors and their innovative profiles. These include ADM Animal Nutrition, Alltech, Inc., Blue Buffalo Pet Products, Inc., Boehringer Ingelheim Animal Health, Ceva Santé Animale, Cipla Limited, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Huvepharma by Olon S.p.a., Kemin Industries, Inc., Krka, d. d., Novo mesto, Lasa Supergenerics Ltd., Leo Bio-Care Pvt. Ltd., Merck & Co., Inc., Nutreco N.V., Phibro Animal Health Corporation, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Fenbendazole Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Compound Formulations
      • Powder
      • Suspension
      • Tablets
    • Pure Substance
  • Disease Type
    • Cancer
      • Breast Cancer
      • Lung Cancer
      • Prostate Cancer
    • Parasitic Infections
      • Gastrointestinal Parasites
      • Lungworms
  • Sales Channel
    • Direct Sales
    • Distributors
    • Online Pharmacies
    • Retail Pharmacies
  • Application
    • Pharmaceutical
      • Animal Medicines
      • Human Medicines
    • Veterinary Medicine
      • Companion Animals
        • Cats
        • Dogs
      • Equine
      • Livestock Animals
        • Cattle
        • Pigs
        • Sheep
  • End User
    • Animal Farms
    • Pharmaceutical Companies
    • Research Institutions
    • Veterinary Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing supportive regulatory policies for the approval and usage of fenbendazole in animal healthcare
5.1.1.2. Rising pet ownership rates globally stimulating the demand for broad-spectrum anthelmintics
5.1.1.3. Intensive livestock farming practices raising the necessity for effective parasitic control solutions
5.1.2. Restraints
5.1.2.1. Cost constraints in developing fenbendazole formulations suited for diverse species
5.1.3. Opportunities
5.1.3.1. Developing combination treatments involving fenbendazole for more comprehensive animal health coverage
5.1.3.2. Introduction of fenbendazole in wildlife management programs to control parasite infestations
5.1.4. Challenges
5.1.4.1. Environmental concerns surrounding fenbendazole's residual impact in agricultural ecosystems
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Fenbendazole Market, by Type
6.1. Introduction
6.2. Compound Formulations
6.2.1. Powder
6.2.2. Suspension
6.2.3. Tablets
6.3. Pure Substance
7. Fenbendazole Market, by Disease Type
7.1. Introduction
7.2. Cancer
7.2.1. Breast Cancer
7.2.2. Lung Cancer
7.2.3. Prostate Cancer
7.3. Parasitic Infections
7.3.1. Gastrointestinal Parasites
7.3.2. Lungworms
8. Fenbendazole Market, by Sales Channel
8.1. Introduction
8.2. Direct Sales
8.3. Distributors
8.4. Online Pharmacies
8.5. Retail Pharmacies
9. Fenbendazole Market, by Application
9.1. Introduction
9.2. Pharmaceutical
9.2.1. Animal Medicines
9.2.2. Human Medicines
9.3. Veterinary Medicine
9.3.1. Companion Animals
9.3.1.1. Cats
9.3.1.2. Dogs
9.3.2. Equine
9.3.3. Livestock Animals
9.3.3.1. Cattle
9.3.3.2. Pigs
9.3.3.3. Sheep
10. Fenbendazole Market, by End User
10.1. Introduction
10.2. Animal Farms
10.3. Pharmaceutical Companies
10.4. Research Institutions
10.5. Veterinary Clinics
11. Americas Fenbendazole Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Fenbendazole Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Fenbendazole Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. FDA approves Safe-Guard for treatment of GI worms in wild quail
14.3.2. Merck acquires Elanco’s Aqua business for USD 1.3 billion
14.3.3. Ceva acquires Scout Bio to expand biotherapeutic initiatives
14.4. Strategy Analysis & Recommendation
14.4.1. Merck & Co., Inc.
List of Figures
FIGURE 1. FENBENDAZOLE MARKET RESEARCH PROCESS
FIGURE 2. FENBENDAZOLE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL FENBENDAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL FENBENDAZOLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. FENBENDAZOLE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. FENBENDAZOLE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. FENBENDAZOLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL FENBENDAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FENBENDAZOLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. FENBENDAZOLE MARKET DYNAMICS
TABLE 7. GLOBAL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FENBENDAZOLE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FENBENDAZOLE MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FENBENDAZOLE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FENBENDAZOLE MARKET SIZE, BY PURE SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FENBENDAZOLE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FENBENDAZOLE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FENBENDAZOLE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FENBENDAZOLE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FENBENDAZOLE MARKET SIZE, BY GASTROINTESTINAL PARASITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FENBENDAZOLE MARKET SIZE, BY LUNGWORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FENBENDAZOLE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FENBENDAZOLE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FENBENDAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FENBENDAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL FENBENDAZOLE MARKET SIZE, BY ANIMAL MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL FENBENDAZOLE MARKET SIZE, BY HUMAN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL FENBENDAZOLE MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL FENBENDAZOLE MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL FENBENDAZOLE MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL FENBENDAZOLE MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL FENBENDAZOLE MARKET SIZE, BY PIGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL FENBENDAZOLE MARKET SIZE, BY SHEEP, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL FENBENDAZOLE MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL FENBENDAZOLE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL FENBENDAZOLE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CANADA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. CANADA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 90. CANADA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. CANADA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 92. CANADA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 93. CANADA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. CANADA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 96. CANADA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 97. CANADA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 98. CANADA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 99. CANADA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. MEXICO FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 104. MEXICO FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 105. MEXICO FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. MEXICO FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 108. MEXICO FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 110. MEXICO FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 111. MEXICO FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES FENBENDAZOLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. CHINA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. CHINA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 152. CHINA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 153. CHINA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 154. CHINA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 155. CHINA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. CHINA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. CHINA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 158. CHINA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 159. CHINA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 160. CHINA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 161. CHINA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. INDIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. INDIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 164. INDIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 165. INDIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 166. INDIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 167. INDIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. INDIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. INDIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 170. INDIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 171. INDIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 172. INDIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 173. INDIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 179. INDONESIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. INDONESIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. INDONESIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 182. INDONESIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 183. INDONESIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 184. INDONESIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. JAPAN FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 188. JAPAN FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 190. JAPAN FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 191. JAPAN FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. JAPAN FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. JAPAN FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 194. JAPAN FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 195. JAPAN FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 196. JAPAN FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 197. JAPAN FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 201. MALAYSIA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 202. MALAYSIA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 203. MALAYSIA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. MALAYSIA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. MALAYSIA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 206. MALAYSIA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 207. MALAYSIA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 208. MALAYSIA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 209. MALAYSIA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 218. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 219. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 220. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 221. PHILIPPINES FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 227. SINGAPORE FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. SINGAPORE FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SINGAPORE FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 230. SINGAPORE FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 231. SINGAPORE FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 232. SINGAPORE FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 233. SINGAPORE FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 242. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH KOREA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. TAIWAN FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. TAIWAN FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 248. TAIWAN FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 249. TAIWAN FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 250. TAIWAN FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 251. TAIWAN FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 252. TAIWAN FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. TAIWAN FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 254. TAIWAN FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 255. TAIWAN FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 256. TAIWAN FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 257. TAIWAN FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. THAILAND FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. THAILAND FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 260. THAILAND FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 261. THAILAND FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 262. THAILAND FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 263. THAILAND FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. THAILAND FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. THAILAND FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 266. THAILAND FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 267. THAILAND FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 268. THAILAND FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 269. THAILAND FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 278. VIETNAM FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 279. VIETNAM FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 280. VIETNAM FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 281. VIETNAM FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA FENBENDAZOLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 295. DENMARK FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. DENMARK FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 297. DENMARK FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 298. DENMARK FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 299. DENMARK FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 300. DENMARK FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. DENMARK FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. DENMARK FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 303. DENMARK FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 304. DENMARK FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 305. DENMARK FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 306. DENMARK FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. EGYPT FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. EGYPT FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 309. EGYPT FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 310. EGYPT FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 311. EGYPT FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 312. EGYPT FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. EGYPT FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. EGYPT FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 315. EGYPT FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 316. EGYPT FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 317. EGYPT FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 318. EGYPT FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. FINLAND FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 320. FINLAND FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 321. FINLAND FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 322. FINLAND FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 323. FINLAND FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 324. FINLAND FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. FINLAND FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. FINLAND FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 327. FINLAND FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 328. FINLAND FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 329. FINLAND FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 330. FINLAND FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. FRANCE FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 332. FRANCE FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 333. FRANCE FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 334. FRANCE FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 335. FRANCE FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 336. FRANCE FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 337. FRANCE FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 338. FRANCE FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 339. FRANCE FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 340. FRANCE FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 341. FRANCE FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 342. FRANCE FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. GERMANY FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 344. GERMANY FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 345. GERMANY FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 346. GERMANY FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 347. GERMANY FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 348. GERMANY FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 349. GERMANY FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 350. GERMANY FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 351. GERMANY FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 352. GERMANY FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 353. GERMANY FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 354. GERMANY FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. ISRAEL FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 356. ISRAEL FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 357. ISRAEL FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 358. ISRAEL FENBENDAZOLE MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 359. ISRAEL FENBENDAZOLE MARKET SIZE, BY PARASITIC INFECTIONS, 2018-2030 (USD MILLION)
TABLE 360. ISRAEL FENBENDAZOLE MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. ISRAEL FENBENDAZOLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 362. ISRAEL FENBENDAZOLE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 363. ISRAEL FENBENDAZOLE MARKET SIZE, BY VETERINARY MEDICINE, 2018-2030 (USD MILLION)
TABLE 364. ISRAEL FENBENDAZOLE MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 365. ISRAEL FENBENDAZOLE MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2030 (USD MILLION)
TABLE 366. ISRAEL FENBENDAZOLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 367. ITALY FENBENDAZOLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 368. ITALY FENBENDAZOLE MARKET SIZE, BY COMPOUND FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 369. ITALY FENBENDAZOLE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION

Companies Mentioned

The leading players in the Fenbendazole market, which are profiled in this report, include:
  • ADM Animal Nutrition
  • Alltech, Inc.
  • Blue Buffalo Pet Products, Inc.
  • Boehringer Ingelheim Animal Health
  • Ceva Santé Animale
  • Cipla Limited
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Huvepharma by Olon S.p.a.
  • Kemin Industries, Inc.
  • Krka, d. d., Novo mesto
  • Lasa Supergenerics Ltd.
  • Leo Bio-Care Pvt. Ltd.
  • Merck & Co., Inc.
  • Nutreco N.V.
  • Phibro Animal Health Corporation
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 874.69 Million
Forecasted Market Value ( USD ) by 2030 $ 1390 Million
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Fenbendazole (CAS 43210-67-9) Global Market Research Report 2024 - Product Image

Fenbendazole (CAS 43210-67-9) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1 - Product Image

Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1

  • Book
  • 328 Pages
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • 1568 Pages
Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030 - Product Image

Febantel Market by Application (Antiparasitic Treatments, Veterinary Medicine), Industry Use (Animal Healthcare, Livestock Management), Formulation Type, Distribution Channel, End-user - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From

About the Fenbendazole Market

Fenbendazole is an anthelmintic drug used in the treatment of parasitic infections in animals. It is commonly used in veterinary medicine to treat gastrointestinal parasites, such as roundworms, hookworms, whipworms, and tapeworms. Fenbendazole is also used to treat other parasites, such as lungworms, giardia, and coccidia. It is available in various forms, including tablets, suspensions, and granules. Fenbendazole is a popular choice for animal pharmaceuticals due to its broad spectrum of activity, low cost, and low toxicity. It is used in a variety of animals, including cats, dogs, horses, cattle, sheep, goats, and pigs. It is also used in aquariums to treat fish parasites. Fenbendazole is widely available in the market, with many companies offering the drug in various forms. Some of the companies in the market include Merck Animal Health, Elanco Animal Health, Bayer Animal Health, Zoetis, and Virbac. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.